IRIS Accounts Production v24.1.0.578 07122543 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 1985 5708 1800 10695 6268 18388 6453 1985 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh071225432023-01-31071225432024-01-31071225432023-02-012024-01-31071225432022-01-31071225432022-02-012023-01-31071225432023-01-3107122543ns15:EnglandWales2023-02-012024-01-3107122543ns14:PoundSterling2023-02-012024-01-3107122543ns10:Director12023-02-012024-01-3107122543ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3107122543ns10:SmallEntities2023-02-012024-01-3107122543ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3107122543ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3107122543ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3107122543ns10:FullAccounts2023-02-012024-01-3107122543ns10:OrdinaryShareClass12023-02-012024-01-3107122543ns10:OrdinaryShareClass22023-02-012024-01-3107122543ns10:OrdinaryShareClass32023-02-012024-01-3107122543ns10:OrdinaryShareClass42023-02-012024-01-310712254342ns10:Director22023-01-310712254342ns10:Director22022-01-310712254342ns10:Director22023-02-012024-01-310712254342ns10:Director22022-02-012023-01-310712254342ns10:Director22024-01-310712254342ns10:Director22023-01-3107122543ns5:CurrentFinancialInstruments2024-01-3107122543ns5:CurrentFinancialInstruments2023-01-3107122543ns5:ShareCapital2024-01-3107122543ns5:ShareCapital2023-01-3107122543ns5:RetainedEarningsAccumulatedLosses2024-01-3107122543ns5:RetainedEarningsAccumulatedLosses2023-01-3107122543ns10:RegisteredOffice2023-02-012024-01-3107122543ns5:MotorVehicles2023-01-3107122543ns5:ComputerEquipment2023-01-3107122543ns5:MotorVehicles2023-02-012024-01-3107122543ns5:ComputerEquipment2023-02-012024-01-3107122543ns5:MotorVehicles2024-01-3107122543ns5:ComputerEquipment2024-01-3107122543ns5:MotorVehicles2023-01-3107122543ns5:ComputerEquipment2023-01-3107122543ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3107122543ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3107122543ns10:OrdinaryShareClass12024-01-3107122543ns10:OrdinaryShareClass22024-01-3107122543ns10:OrdinaryShareClass32024-01-3107122543ns10:OrdinaryShareClass42024-01-3107122543ns10:Director22023-02-012024-01-31071225431ns10:Director12023-01-31071225431ns10:Director12022-01-31071225431ns10:Director12023-02-012024-01-31071225431ns10:Director12022-02-012023-01-31071225431ns10:Director12024-01-31071225431ns10:Director12023-01-31
REGISTERED NUMBER: 07122543 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st January 2024

for

Dr D Bose Medical Services Ltd

Dr D Bose Medical Services Ltd (Registered number: 07122543)






Contents of the Financial Statements
for the Year Ended 31st January 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Dr D Bose Medical Services Ltd (Registered number: 07122543)

Balance Sheet
31st January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 24,909 31,286
Investments 5 100,694 98,182
125,603 129,468

CURRENT ASSETS
Debtors 6 4,567 5,320
Investments 7 98,000 98,000
Cash at bank 412,018 354,960
514,585 458,280
CREDITORS
Amounts falling due within one year 8 20,053 11,092
NET CURRENT ASSETS 494,532 447,188
TOTAL ASSETS LESS CURRENT
LIABILITIES

620,135

576,656

PROVISIONS FOR LIABILITIES 4,733 5,944
NET ASSETS 615,402 570,712

CAPITAL AND RESERVES
Called up share capital 9 105 105
Retained earnings 615,297 570,607
SHAREHOLDERS' FUNDS 615,402 570,712

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dr D Bose Medical Services Ltd (Registered number: 07122543)

Balance Sheet - continued
31st January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23rd October 2024 and were signed on its behalf by:





Dr D Bose - Director


Dr D Bose Medical Services Ltd (Registered number: 07122543)

Notes to the Financial Statements
for the Year Ended 31st January 2024

1. COMPANY INFORMATION

Dr D Bose Medical Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07122543

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Computer equipment - 25% on cost
Motor Vehicles - 20% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Dr D Bose Medical Services Ltd (Registered number: 07122543)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1st February 2023
and 31st January 2024 76,015 3,972 79,987
DEPRECIATION
At 1st February 2023 44,879 3,822 48,701
Charge for year 6,227 150 6,377
At 31st January 2024 51,106 3,972 55,078
NET BOOK VALUE
At 31st January 2024 24,909 - 24,909
At 31st January 2023 31,136 150 31,286

5. FIXED ASSET INVESTMENTS

Fixed asset investments represent holdings in unit trusts and at each reporting date the increase/decrease in fair value is measured immediately in the profit and loss.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade debtors 4,000 4,000
S455 recoverable - 952
Prepayments and accrued income 567 368
4,567 5,320

7. CURRENT ASSET INVESTMENTS
31.1.24 31.1.23
£    £   
Unlisted investments 98,000 98,000

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Tax 13,600 9,107
Directors' current accounts 6,453 1,985
20,053 11,092

Dr D Bose Medical Services Ltd (Registered number: 07122543)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2024

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
85 Ordinary A £1 85 85
10 Ordinary B £1 10 10
5 Ordinary C £1 5 5
5 Ordinary D £1 5 5
105 105

The A & B shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The rights of the C & D shares are as follows:The shares will not be entitled to receive notice of, or attend or vote at any general meeting of the company.In the event of the winding-up, sale or other return on capital in the company, the holders of the shares will be entitled to receive payment of the capital paid up on such shares together with the holders of any other class of shares in issue. Following the repayment of all paid up share capital to all shareholders entitled to receive repayment of the capital paid upon their shares, the shares shall not confer the right to any further or other participation in the profits or assets of the company. A divided may be paid in respect of these classes of shares respectively to the exclusion of any other class of share currently in issue. Where a dividend is declared in respect of all classes of share the company may, by Ordinary Resolution, differentiate between this and any or all other classes as to the amount or percentage of dividend payable, but by default the share in these classes currently in issue, unless the rights attached to such other class specify otherwise.

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st January 2024 and 31st January 2023:

31.1.24 31.1.23
£    £   
Dr D Bose and Mrs A Bose
Balance outstanding at start of year (1,985 ) 5,708
Amounts advanced 1,800 10,695
Amounts repaid (6,268 ) (18,388 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (6,453 ) (1,985 )

The loan is repayable on demand and no interest was charged during the year.

11. CONTROL

The ultimate controlling party is Dr D Bose by virtue of his majority share of the voting share capital.